• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Home
  • LinkedIn
  • Twitter

  • About Us
    • Overview
    • Executive Committee
    • Board Of Directors
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • Our Technology
      • TIM
      • shRNA
      • shARC Platform
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Careers
  • Contact Us

Celyad Announces May 2019 Investor Conference Schedule

May 2, 2019 By Celyad

Mont-Saint-Guibert, Belgium – Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that management plans to attend the following events in May 2019:


Conference details:

5th Annual SunTrust Robinson Humphrey (STRH) Life Sciences Summit

Date: Wednesday, May 8, 2019

Location: New York, NY

CAR-T and The Rise of the Cellicon Valley

Date: Friday, May 10, 2019

Presentation Time: 3:30 p.m.  EDT         

Location: Philadelphia, PA

Sachs 5th Annual Immuno-Oncology BD&L and Investment Forum

Date: Friday, May 31, 2019

Presentation Time: 11:50 a.m. EDT

Location: Chicago, IL

Download press release(s)
Communiqué de presse
Press Release

Filed Under: Corporate, Non-regulated

Footer

Celyad Oncology

Celyad Oncology Logo
  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.

  • Cookie Policy |
  • Privacy Policy |
  • Terms of Use